EDITORIAL
Published on 26 May 2023
Editorial: Chagas disease novel drug targets and treatments
doi 10.3389/fcimb.2023.1199715
- 2,226 views
- 2 citations
- Frontiers in Cellular and Infection Microbiology
- Clinical Microbiology
- Research Topics
- Chagas Disease Novel Drug Targets and Treatments
Chagas Disease Novel Drug Targets and Treatments
7,152
Total downloads
38k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 30 Nov 2022
In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance
doi 10.3389/fcimb.2022.1017040
- 2,109 views
- 10 citations
ORIGINAL RESEARCH
Published on 29 Jul 2022
The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance
doi 10.3389/fcimb.2022.926699
- 3,534 views
- 12 citations
BRIEF RESEARCH REPORT
Published on 28 Jul 2022
Broadening the spectrum of ivermectin: Its effect on Trypanosoma cruzi and related trypanosomatids
doi 10.3389/fcimb.2022.885268
- 3,554 views
- 8 citations
ORIGINAL RESEARCH
Published on 14 Jul 2022
The Use of AlphaFold for In Silico Exploration of Drug Targets in the Parasite Trypanosoma cruzi
doi 10.3389/fcimb.2022.944748
- 4,235 views
- 11 citations
ORIGINAL RESEARCH
Published on 07 Jul 2022
The Role of the Na+/Ca2+ Exchanger in Aberrant Intracellular Ca2+ in Cardiomyocytes of Chagas-Infected Rodents
doi 10.3389/fcimb.2022.890709
- 10,538 views
- 2 citations
ORIGINAL RESEARCH
Published on 06 Jul 2022
Structural New Data for Mitochondrial Peroxiredoxin From Trypanosoma cruzi Show High Similarity With Human Peroxiredoxin 3: Repositioning Thiostrepton as Antichagasic Drug
doi 10.3389/fcimb.2022.907043
- 1,851 views
- 4 citations
ORIGINAL RESEARCH
Published on 05 Jul 2022
Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy
doi 10.3389/fcimb.2022.855119
- 1,682 views
- 8 citations
MINI REVIEW
Published on 30 Jun 2022
Role of the Complement System in the Modulation of T-Cell Responses in Chronic Chagas Disease
doi 10.3389/fcimb.2022.910854
- 1,608 views
- 3 citations
ORIGINAL RESEARCH
Published on 06 May 2022
The Impact of the CTHRSSVVC Peptide Upon Experimental Models of Trypanosoma cruzi Infection
doi 10.3389/fcimb.2022.882555
- 1,928 views
ORIGINAL RESEARCH
Published on 11 Mar 2022
Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC
doi 10.3389/fcimb.2021.785166
- 2,154 views
- 3 citations
Published in
Frontiers in Cellular and Infection Microbiology
- Clinical Microbiology
- Parasite and Host
Impact
- 38kTopic views
- 30kArticle views
- 7,152Article downloads